Alendronate Sodium Patent Expiration
Alendronate Sodium was first introduced by Organon Llc A Sub Of Organon And Co
Alendronate Sodium Patents
Given below is the list of patents protecting Alendronate Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Binosto | US9592195 | Stable effervescent bisphosphonate formulations with rapid solubilization characteristics | Dec 05, 2031 | Radius |
| Binosto | US7488496 | Effervescent compositions comprising bisphosphonates and methods related thereto |
Aug 11, 2023
(Expired) | Radius |
| Binosto | US7964212 | Effervescent compositions comprising phosphonates and methods related thereto |
Mar 06, 2023
(Expired) | Radius |
| Fosamax |
US5994329 (Pediatric) | Method for inhibiting bone resorption |
Jan 17, 2019
(Expired) | Merck |
| Fosamax |
US6015801 (Pediatric) | Method for inhibiting bone resorption |
Jan 17, 2019
(Expired) | Merck |
| Fosamax |
US6225294 (Pediatric) | Method for inhibiting bone resorption |
Jan 17, 2019
(Expired) | Merck |
| Fosamax | US5994329 | Method for inhibiting bone resorption |
Jul 17, 2018
(Expired) | Merck |
| Fosamax | US6015801 | Method for inhibiting bone resorption |
Jul 17, 2018
(Expired) | Merck |
| Fosamax | US6225294 | Method for inhibiting bone resorption |
Jul 17, 2018
(Expired) | Merck |
| Fosamax |
US5462932 (Pediatric) | Oral liquid alendronate formulations |
Nov 17, 2014
(Expired) | Merck |
| Fosamax | US5462932 | Oral liquid alendronate formulations |
May 17, 2014
(Expired) | Merck |
| Fosamax |
US5358941 (Pediatric) | Dry mix formulation for bisphosphonic acids with lactose |
Jun 02, 2013
(Expired) | Organon |
| Fosamax |
US5681590 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon |
| Fosamax |
US6090410 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon |
| Fosamax |
US6194004 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon |
| Fosamax | US5358941 | Dry mix formulation for bisphosphonic acids with lactose |
Dec 02, 2012
(Expired) | Organon |
| Fosamax | US5681590 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon |
| Fosamax | US6090410 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon |
| Fosamax | US6194004 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon |
Alendronate Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List